Related Experiment Video
Updated: Jun 4, 2026

Determining the Serum Stability of Human Adenosine Deaminase 1 Enzyme
Published on: September 27, 2024
Primary adenosine monophosphate (AMP) deaminase deficiency in a hypotonic infant
Manuel Castro-Gago1, Carmen Gómez-Lado, Laura Pérez-Gay
1Servicio de Neuropediatría, Hospital Clínico Universitario, Facultad de Medicina, Universidad de Santiago de Compostela, Santiago de Compostela, Spain. manuel.castro.gago@usc.es
Insights
Adenosine monophosphate (AMP) deaminase deficiency spectrum includes exercise-induced muscle pain and rare congenital weakness. This study identifies a homozygous mutation linked to congenital hypotonia, suggesting a primary AMP deaminase deficiency presentation.
Area of Science:
- Biochemistry
- Genetics
- Neuromuscular Disorders
Background:
- Adenosine monophosphate (AMP) deaminase deficiency presents a wide clinical spectrum, from asymptomatic carriers to exercise-induced myopathy.
- Congenital muscle weakness and hypotonia have been rarely associated with AMP deaminase deficiency prior to molecular diagnostics.
Observation:
- A 6-month-old female infant presented with congenital muscle weakness and hypotonia.
- Genetic analysis revealed a homozygous C to T mutation at nucleotide 34 of the adenosine monophosphate deaminase-1 gene.
Findings:
- The patient exhibited muscle deficiency of adenosine monophosphate deaminase.
- This homozygous mutation is associated with congenital muscle weakness and hypotonia.
Implications:
- This case suggests that primary adenosine monophosphate deaminase deficiency can manifest as congenital muscle weakness and hypotonia.
- Highlights the importance of genetic analysis in diagnosing rare neuromuscular disorders.
- Expands the known clinical spectrum of AMP deaminase deficiency.
Abstract:
The spectrum of the adenosine monophosphate (AMP) deaminase deficiency ranges from asymptomatic carriers to patients who manifest exercise-induced muscle pain, occasionally rhabdomyolysis, and idiopathic hyperCKemia. However, previous to the introduction of molecular techniques, rare cases with congenital weakness and hypotonia have also been reported. We report a 6-month-old girl with the association of congenital muscle weakness and hypotonia, muscle deficiency of adenosine monophosphate deaminase, and the homozygous C to T mutation at nucleotide 34 of the adenosine monophosphate deaminase-1 gene. This observation indicates the possible existence of a primary adenosine monophosphate deaminase deficiency manifested by congenital muscle weakness and hypotonia.
Related Concept Videos
Hydrolysis of ATP
If one phosphate group is removed, a molecule of ADP—adenosine diphosphate—remains, along with inorganic phosphate. ADP can be further hydrolyzed to AMP—adenosine monophosphate—by the removal of a second...
ATP Synthase: Structure
Inborn Errors of Metabolism
ATP Synthase: Mechanism
RNA Editing
cAMP-dependent Protein Kinase Pathways
